In humans, mutations in ECO1 orthologs (termed ESCO1/EFO1 and ESCO2/EFO2) collectively correlate with numerous forms of cancer, including melanoma and prostate cancer, and a severe developmental abnormality called Roberts Syndrome (RBS) [15–20]. This evidence concerns the gene ESCO1 and prostate carcinoma.